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JEJUNUM OR STOMACH FOR THE PANCREATIC
ANASTOMOSIS AFTER PANCREATICODUODENECTOMY
ABSTRACT
Yeo, C.J., Cameron, J.L., Maher, M.M., Sauter, P.K., Zahurak, M.L., Talamini, M.A.,
Lillernoe, K.D. and Pitt, H.A. (1995) A prospective randomized trial of pancreatico-
gastrostomy versus pancreaticojejunostorny after pancreaticoduodenectomy. Annals of
Surgery; 222: 580-592.
Objective: The authors hypothesized that pancreaticogastrostomy is safer than pan-
creaticojejunostomy after pancreaticoduodenectomy and less likely to be associated with
a postoperative pancreatic fistula.
Summary Background Data: Pancreatic fistula is a leading cause of morbidity and
mortality after pancreaticoduodenectomy, occurring in 10% to 20% of patients.
Nonrandomized reports have suggested that pancreaticogastrostomy is less likely than
pancreaticojejunostomy to be associated with postoperative complications.
Methods: Between May 1993 and January 1995, the findings for 145 patients were
analyzed in this prospective trial at The Johns Hopkins Hospital. After giving their
appropriate preoperative informed consent, patients were randomly assigned to pan-
creaticogastrostomy or pancreaticojejunostomy after completion of the pancreatico-
duodenal resection. All pancreatic anastomoses were performed in two layers without
pancreatic duct stents and with closed suction drainage. Pancreatic fistula was defined as
drainage of greater than 50 mL of amylase-rich fluid on or after postoperative day 10.
Results: The pancreaticogastrostomy (n=73) and pancreaticojejunostomy (n=72)
groups were comparable with regard to multiple parameters, including demographics,
medical history, preoperative laboratory values, and intraoperative factors, such as
operative time, blood transfusions, pancreatic texture, length of pancreatic remnant
mobilized, and pancreatic duct diameter. The overall incidence of pancreatic fistula
after pancreaticoduodenectomy was 11.7% (171145). The incidence of pancreatic fis-
tula was similar for the pancreaticogastrostomy (12.3%) and pancreaticojejunostomy
(11.1%) groups. Pancreatisc fistula was associated with a significant prolongation of
postoperative hospital stay (36+5 vs. 15+1 days) (p<0.001). Factors significantly
increasing the risk of pancreatic fistula by univariate logistic regression analysis192 HPB INTERNATIONAL
included ampullary or duodenal disease, soft pancreatic texture, longer
operative time, greater intraoperative red blood cell transfusions, and lower surgical
volume (p<0.05). A multivariate logistic regression analysis revealed the factors most
highly associated with pancreatic fistula to be lower surgical volume and ampullary or
duodenal disease in the resected specimen.
Conclusions: Pancreatic fistula is a common complication after pancreatic-
oduodenectomy, with an incidence most strongly associated with surgical volume and
underlying disease. These data do not support the hypothesis that pancreatic-
ogastrostomy is safer than pancreaticojejunostomy or is associated with a lower inci-
dence of pancreatic fistula.
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PAPERDISCUSSION
The main message of this study is that it is difficult to
improve on success. The authors set out to test the
hypothesis that pancreaticogastrostomy is less likely
to lead to an anastomotic fistula than is pancreaticoje-
junostomy, a finding espoused in collective experiences
ofproponents ofusing the stomach for reconstruction.
They devised and planned a study with sufficient
power to show a significant difference if the projected
pancreatico-enteric fistula rate would be 20% and the
alternate treatment reduced it to 5%. Neither projected
outcome occurred; that is, the pancreaticojejunal fistula
rate was only 11% and the pancreaticogastrostomy rate
was 12%. The conclusion is clear that the two methods
were equivalent. But equally clear is that it is hard to do
better than the best, and these fistula rates are among
the lowest reported.
The relatively smallnumber offistulaswhich did occur
seem therefore to be less a function of the anastomotic
technique than ofother circumstances. The studyshowed
in fact that, while most variables had no discernable
impact on the likelihood ofa pancreaticfistula occurring,
there was a significant correlation with two factors.
The first is with the volume ofsuch surgery performed by
the surgeon. The risk of a fistula was inversely related
to thepancreaticoduodenectomyexperience ofthesurgeon.
This finding, ofcourse, is similar-and probably causally
related- to the lower mortality rates observed in high-
volume vs. low-volume settings’2.
Second, multivariate analysis showed a greater risk
of anastomotic fistula in patients with "duodenal" or
"ampullary" (and bile duct) pathology as compared
with a primary pancreatic disease. While the statistical
analysis emphasizes this descriptor of the significant
"independent variable," it is clear that the link between
that type ofdisease and the adverse event must be and
is the texture ofthe pancreas in those diseases, soft vs.
firm, fibrotic or not, capable ofholding sutures securely
or easily disrupted. The study implies that either tech-
nique is just as good or just as bad in the high-risk
circumstance. The study does not address or answer
whether octreotide has a salutary role in preventing
fistulas in these cases.
The authors seem to imply that because there was
no difference in the outcomes from the two methods,
there is no compelling reason to prefer one over the
other. In fact they give no criteria for choosing.
Nonetheless, there would seem to be a difference
regarding the practical implications, if not the risks,
between the two types offistula. For example, I assume
that the treatment of a gastric-origin fistula would
require fasting and TPN until successful closure. In
contrast a jejunal-origin fistula, especially from an
isolated roux-en-y loop might allow the patient to eat
(and go home) while the fistula continued to heal. One
might therefore predict the ability ofthe lattertechnique
to shorten the period of morbidity, hospitalization,
and cost.
Also, while no patient in this series required a
reoperation for uncontrolled sepsis and its compli-
cations, such situations do arise and usually are best
controlled by amputation ofthe pancreatic stump and
the attached/dehisced anastomosis. If the stomach is
involved in the. dehiscence, it is worrisome that
management ofthe gastrostomy will be more difficult
and risky.
There are still questions to be answered about the
pancreatico-gastrostomy. Do these anastomoses remain
patent and functional? Are there long-term compli-
cations? Ifthere is delayed gastric emptying, as is noted in
about 30% of pylorus-preserving operations3’4, is there
greater risk of pancreatico-gastric anastomotic failure?
For now, we are left with not much more than ourHPB INTERNATIONAL 193
pre-existingbias tochoosebetweeen thesetwotechniques.
For myself, I will continue with what works for me:
pancreaticojejunostomy. As Will Rogers, a sage
American humorist said 60 years ago, "If it ain’t
broke, don’t fix it".
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